LGALS3 and neurodegenerative disease: A significant difference in galectin-3 expression was found between patients with neurodegenerative diseases and healthy individuals (MDS = 0.85, 95% CI 0.53–1.18, p < 0.00001), but no differences were found for galectin-1 and 9 (Figure 3b).